Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
CBP (CREB (cAMP responsive element binding protein) binding protein (CREBBP)) and P300 (adenovirus E1A-associated 300 kDa protein) are two closely related histone acetyltransferases (HATs) that play a key role in the regulation of gene transcription. Both proteins contain a bromodomain flanking the...
Main Authors: | Popp, T, Tallant, C, Rogers, C, Fedorov, O, Brennan, P, Müller, S, Knapp, S, Bracher, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Chemical Society
2016
|
Similar Items
-
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
by: Hammitzsch, A, et al.
Published: (2015) -
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
by: Hay, D, et al.
Published: (2014) -
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
by: Picaud, S, et al.
Published: (2015) -
CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation
by: Olzscha, H, et al.
Published: (2016) -
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
by: Ebrahimi, A, et al.
Published: (2019)